Showing results (1471-1480 of 1,729) with videos related to
Sort By:
Pageof 173
Clinical Breast Cancer|November 10, 2024
Engaging Multidisciplinary Teams to Develop Pragmatic Clinical Practice Guidelines to Support Management of Patients With High-Risk Breast LesionsHeather B Neuman, Lee G Wilke, Laura M Bozzuto, et al.Frontiers in Endocrinology|April 24, 2024
Hair cortisol levels are associated with overweight and obesity in the ELSA-Brasil cohortKarine Lino Rodrigues, Patrícia de Oliveira da Silva Scaranni, Evelyn Nunes Goulart da Silva Pereira, et al.Bioanalysis|December 22, 2011
Conference report: the 3rd Global CRO Council for Bioanalysis at the International Reid Bioanalytical ForumMassimo Breda, Fabio Garofolo, Maria Cruz Caturla, et al.Archives of Gynecology and Obstetrics|April 12, 2020
Prognostic role of thrombocytosis in recurrent ovarian cancer: a pooled analysis of the AGO Study GroupUlrich Canzler, Hans-Joachim Lück, Petra Neuser, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
Topotecan plus carboplatin versus standard therapy with paclitaxel plus carboplatin (PC) or gemcitabine plus carboplatin (GC) or pegylated liposomal doxorubicin plus carboplatin (PLDC): a randomized phase III trial of the NOGGO-AGO-Study Group-AGO Austria and GEICO-ENGOT-GCIG intergroup study (HECTOR)J Sehouli, R Chekerov, A Reinthaller, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|December 28, 2023
Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR11/ICON-7Sabine Heublein, Jacobus Pfisterer, Andreas du Bois, et al.JAMA Oncology|October 8, 2020
Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical TrialIsabelle Ray-Coquard, Philipp Harter, Domenica Lorusso, et al.Medicinal Research Reviews|December 30, 2014
Miniaturized Cultivation of Microbiota for Antimalarial Drug DiscoveryCarrie Waterman, Laurent Calcul, Jeremy Beau, et al.International Journal of Molecular Sciences|September 5, 2019
Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain TumorAlexandra Russo, Claudia Paret, Francesca Alt, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 14, 2022
Impact of substage and histologic type in stage I ovarian carcinoma survival: a multicenter retrospective observational studyMajdi Imterat, Nicolò Bizzarri, Robert Fruscio, et al.Pageof 173